(Q40812995)

English

Systemic administration of autologous, alloactivated helper-enriched lymphocytes to patients with metastatic melanoma of the lung. A phase I study.

scientific article published on January 1986

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2936447%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

Systemic administration of autologous, alloactivated helper-enriched lymphocytes to patients with metastatic melanoma of the lung. A phase I study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2936447%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

metastatic melanoma

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2936447%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

Carlo Gambacorti-Passerini

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2936447%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

Donatella Taramelli

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2936447%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

author name string

R Marolda

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2936447%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

G Sciorelli

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2936447%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

G Tona

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2936447%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

E Cosulich

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2936447%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

G Fossati

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2936447%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

G Parmiani

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2936447%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

N Cascinelli

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2936447%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

publication date

1 January 1986

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2936447%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2936447%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2936447%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2936447%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

148-155

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2936447%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

https://scigraph.springernature.com/pub.10.1007/bf00199863

0 references

Human natural killer cells: biologic and pathologic aspects

1 reference

https://pubmed.ncbi.nlm.nih.gov/2936447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation between lymphocyte-mediated auto-tumor reactivities and clinical course. I. Evaluation of 46 patients with sarcoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2936447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T cell-mediated immunosuppression as an obstacle to adoptive immunotherapy of the P815 mastocytoma and its metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/2936447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of low-dose recombinant leukocyte A interferon in disseminated malignant melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2936447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human T cell subpopulations defined by a monoclonal antibody. I. A small subset is responsible for proliferation to allogeneic cells or to soluble antigens and for helper activity for B cell differentiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/2936447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lysis of tumor biopsy cells by autologous T lymphocytes activated in mixed cultures and propagated with T cell growth factor.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2936447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2

1 reference

https://pubmed.ncbi.nlm.nih.gov/2936447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/2936447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of human melanoma growth in nude mice by autologous, alloactivated peripheral blood lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2936447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lysis of syngeneic solid tumor cells by alloantigen stimulated mouse T and non-T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2936447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lysis of autologous human melanoma cells by in vitro allosensitized peripheral blood lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2936447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Generation of cytotoxic T lymphocytes to autologous human leukaemia cells by sensitisation to pooled allogeneic normal cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2936447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2936447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T-lymphocyte subpopulations in peripheral blood and tissues of cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/2936447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HLA-DR histocompatibility leukocyte antigens permit cultured human melanoma cells from early but not advanced disease to stimulate autologous lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2936447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of passively transferred immunity against an established tumor depends on generation of cytolytic T cells in recipient. Inhibition by suppressor T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2936447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2- lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2936447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human large granular lymphocytes are potent producers of interleukin-1.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2936447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphokines: their role in lymphocyte responses. Properties of interleukin 1.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2936447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized trial of levamisole versus placebo as adjuvant therapy in malignant melanoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2936447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful immunotherapy of natural killer-resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by interleukin 2

1 reference

https://pubmed.ncbi.nlm.nih.gov/2936447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation between lymphocyte-mediated auto-tumor reactivities and the clinical course. II. Evaluation of 69 patients with lung carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2936447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized trial of adjuvant chemotherapy and immunotherapy in cutaneous melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2936447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alloreactivity and tumor antigens: generation of syngeneic antilymphoma killer lymphocytes by alloimmunization of mice with normal cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2936447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of human interferon-alpha therapy on cytotoxic functions of blood lymphocytes. Studies on lectin-dependent cellular cytotoxicity, antibody-dependent cellular cytotoxicity, and natural killer cell activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/2936447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumour-reactive lymphocytes stimulated in mixed lymphocyte and tumour culture. Clonal analysis of effector cells in cytotoxic and proliferative assays

1 reference

https://pubmed.ncbi.nlm.nih.gov/2936447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of antibody-coated red cells for the sensitive detection of antigen and in rosette tests for cells bearing surface immunoglobulins

1 reference

https://pubmed.ncbi.nlm.nih.gov/2936447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human anti-lymphoma responses generated in vitro and in vivo following sensitization with allogeneic leukocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2936447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lysis of human solid tumors by autologous cells sensitized in vitro to alloantigens

1 reference

https://pubmed.ncbi.nlm.nih.gov/2936447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunotherapy of a chemically-induced sarcoma in rats: characterization of the effector T cell subset and nature of suppression

1 reference

https://pubmed.ncbi.nlm.nih.gov/2936447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Perusing the ASCO abstracts with a focus on interferons in malignant melanoma and renal cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2936447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunoincompetence in cancer patients. Assessment by in vitro stimulation tests and quantification of lymphocyte subpopulations

1 reference

https://pubmed.ncbi.nlm.nih.gov/2936447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic administration of human leukocyte interferon to melanoma patients. I. Effects on natural killer function and cell population

1 reference

https://pubmed.ncbi.nlm.nih.gov/2936447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Passive adoptive immunotherapy of low-immunogenic BALB/C lymphoma by syngeneic alloimmune T lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2936447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin 1, a potential regulator of fibroblast proliferation

1 reference

https://pubmed.ncbi.nlm.nih.gov/2936447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon production and tumor cell killing by human lymphocytes stimulated in mixed-lymphocyte culture

1 reference

https://pubmed.ncbi.nlm.nih.gov/2936447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary but not metastatic human melanomas expressing dr antigens stimulate autologous lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2936447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Depressed levels of granular lymphocytes with natural killer (NK) cell function in 247 cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/2936447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study of the adoptive immunotherapy of human cancer with lectin activated autologous mononuclear cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2936447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allostimulation of patients' lymphocytes generates both T and NK-like cells cytotoxic for autologous melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2936447

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40812995&oldid=1527864057"